Insufficient scRNA-seq data for expression of B3GNT4 at single-cell level.
Insufficient scRNA-seq data for expression of B3GNT4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 92% | 195.24 | 82 / 89 | 58% | 3.25 | 523 / 901 |
brain | 92% | 286.27 | 2429 / 2642 | 22% | 0.50 | 155 / 705 |
lung | 47% | 22.06 | 273 / 578 | 53% | 1.60 | 614 / 1155 |
adrenal gland | 28% | 22.83 | 71 / 258 | 66% | 6.54 | 151 / 230 |
skin | 80% | 184.14 | 1450 / 1809 | 8% | 0.20 | 36 / 472 |
esophagus | 38% | 38.49 | 556 / 1445 | 49% | 1.26 | 89 / 183 |
uterus | 7% | 4.09 | 12 / 170 | 56% | 1.50 | 257 / 459 |
spleen | 61% | 28.42 | 147 / 241 | 0% | 0 | 0 / 0 |
prostate | 52% | 23.65 | 127 / 245 | 7% | 0.12 | 35 / 502 |
intestine | 35% | 14.45 | 339 / 966 | 24% | 0.53 | 124 / 527 |
tonsil | 0% | 0 | 0 / 0 | 53% | 1.35 | 24 / 45 |
thymus | 51% | 21.75 | 331 / 653 | 2% | 0.03 | 10 / 605 |
stomach | 21% | 8.65 | 74 / 359 | 24% | 0.50 | 69 / 286 |
ovary | 12% | 6.66 | 22 / 180 | 32% | 0.63 | 138 / 430 |
bladder | 5% | 1.48 | 1 / 21 | 39% | 1.10 | 198 / 504 |
pancreas | 13% | 4.47 | 41 / 328 | 20% | 0.41 | 36 / 178 |
breast | 17% | 6.88 | 79 / 459 | 13% | 0.25 | 147 / 1118 |
peripheral blood | 16% | 7.68 | 145 / 929 | 0% | 0 | 0 / 0 |
liver | 10% | 4.40 | 22 / 226 | 4% | 0.11 | 18 / 406 |
adipose | 8% | 3.29 | 92 / 1204 | 0% | 0 | 0 / 0 |
muscle | 3% | 1.60 | 24 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 2% | 0.84 | 23 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
heart | 1% | 0.29 | 7 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016266 | Biological process | O-glycan processing |
GO_0030311 | Biological process | poly-N-acetyllactosamine biosynthetic process |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0018146 | Biological process | keratan sulfate biosynthetic process |
GO_0000139 | Cellular component | Golgi membrane |
GO_0008499 | Molecular function | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
GO_0008532 | Molecular function | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity |
Gene name | B3GNT4 |
Protein name | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 4 (EC 2.4.1.149) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4) (BGnT-4) (Beta-1,3-Gn-T4) (Beta-1,3-N-acetylglucosaminyltransferase 4) (Beta3Gn-T4) UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 |
Synonyms | UNQ1898/PRO4344 |
Description | FUNCTION: Beta-1,3-N-acetylglucosaminyltransferase involved in the synthesis of poly-N-acetyllactosamine. Has activity for type 2 oligosaccharides. . |
Accessions | ENST00000324189.5 [Q9C0J1-1] ENST00000546192.1 [Q9C0J1-2] ENST00000535274.1 [Q9C0J1-2] Q9C0J1 ENST00000537991.1 A0A2R8YCM2 |